Chapter 18. Drugs Affecting the Hematopoietic System

 

 

____      1.         The routine monitoring recommended for low molecular weight heparin is:

1.

INR every 2 days until stable, then weekly

2.

aPTT every week while on therapy

3.

Factor Xa levels if the patient is pregnant

4.

White blood cell count every 2 weeks

 

 

____      2.         When writing a prescription for warfarin it is common to write _________ on the prescription.

1.

OK to substitute for generic

2.

The brand name of warfarin and Do Not Substitute

3.

PRN refills

4.

Refills for 1 year

 

 

____      3.         Education of patients who are taking warfarin includes discussing their diet. Instructions include:

1.

Avoiding all vitamin K-containing foods

2.

Avoiding high-vitamin K-containing foods

3.

Increasing intake of iron-containing foods

4.

Making sure they eat 35 grams of fiber daily

 

 

____      4.         Patients who are being treated with epoetin alfa need to be monitored for the development of:

1.

Thrombocytopenia

2.

Neutropenia

3.

Hypertension

4.

Gout

 

 

____      5.         The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:

1.

ESAs no longer be prescribed to patients with chronic renal failure

2.

The risk of tumor development be explained to cancer patients on ESA therapy

3.

Patients should no longer receive ESA therapy to prepare for allogenic transfusions

4.

ESAs be prescribed only to patients younger than age 60 years

 

 

____      6.         When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:

1.

6 weeks if they are a cancer patient

2.

1 week if they have chronic renal failure

3.

2 weeks if they are taking it for allogenic transfusion

4.

Each week throughout therapy

 

 

____      7.         Jim is having a hip replacement surgery and would like to self-donate blood for the surgery. In addition to being prescribed epogen alpha he should also be prescribed:

1.

Folic acid to prevent megaloblastic anemia

2.

Iron, to start when the epogen starts

3.

An antihypertensive to counter the adverse effects of epogen

4.

Vitamin B12 to prevent pernicious anemia

 

 

____      8.         Monitoring for a patient being prescribed iron for iron deficiency anemia includes:

1.

Reticulocyte count 1 week after therapy is started

2.

Complete blood count every 2 weeks throughout therapy

3.

Hemoglobin level at 1 week of therapy

4.

INR weekly throughout therapy

 

No comments found.
Login to post a comment
This item has not received any review yet.
Login to review this item
No Questions / Answers added yet.
Price $17.00
Add To Cart

Buy Now
Category NR AND NUR Exams
Comments 0
Rating
Sales 0

Buy Our Plan

We have

The latest updated Study Material Bundle with 100% Satisfaction guarantee

Visit Now
{{ userMessage }}
Processing